RxDoctor Payments Data

Frank Silvestry, MD

Cardiovascular Disease · Philadelphia, PANPI 1548346364

Payments from drug & device makers

$1,085in general payments, 2019–2025

Across 20 payments — averaging $54.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$813
  • Boston Scientific$150
  • Edwards Lifesciences$76
  • GE HealthCare$32
  • Lantheus Medical Imaging, Inc.$15

What the payments were for

  • Travel & lodging$22421%
  • Food & beverage$86179%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,085 in reported general payments places this provider in the 40th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$146,840
Medicare patients
845
Services billed
3,002

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban275$350,814
Repatha SureclickEvolocumab125$83,818
EntrestoSacubitril/Valsartan55$77,316
XareltoRivaroxaban27$39,957
Praluent PenAlirocumab39$33,155
JardianceEmpagliflozin24$26,896
Rosuvastatin Calcium366$8,479
Ezetimibe259$7,953
VascepaIcosapent Ethyl13$5,764
Metoprolol Succinate407$5,643
Atorvastatin Calcium400$5,167
SynthroidLevothyroxine Sodium29$4,347
Potassium Chloride55$3,677
Pitavastatin Calcium17$3,449
Dofetilide24$3,147

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →